- High single digit earnings growth at 9x P/E, EUR 0.7 EPS normalized for covid-19 lockdown. 7.5x P/E if adjusting for other “one-offs”. Could get to EUR 1.1 EPS within 5yrs. Comps trade in high teens or 20x P/E.
o Mid single digit organic revenue growth given exposure to growing end markets (E-commerce, value retail, fragrancenet etc.) – grew 10% in 2018 and 4.9% in 2019
o Margin at 4.4% 2019 EBIT depressed because of one-offs; adjusted for certain temporary effects, margin was 5.5%. Adjustments:
▪ 1) Asia low profitability of 0% gross margin given Hong Kong protests and trade wars impacting demand – should be say 10% so that’s 15m extra gross
profit, so 0.5%+ on group margin
▪ 2) Delay of warehouse where they had to hire a lot of people in B&S segment in 2019 – could be another 7.5m so 0.4%
▪ Normalized margin is 5.5%. Also seems reasonable top down. Normal margin 6-7% for peer companies. Earnings should therefore grow more than revenue
- Growth of underlying markets – growth approx. 5%
o Company exposed to e-commerce (25% of revenue), high growth value retailers (11%) – both categories growing double digit
o Travel retail (7% of revenue) used to grow c. 5% per year
o Other segments low to mid single digit
- Mgmt and MDs of divisions very aligned given ownership and have created value over time
- Bolt-on acquisitions likely to provide additional upside – good acquisition track record
o Model is to buy companies at 6-8x EBITDA pre synergies, don’t believe in turnaround
companies, mgmt stays on board and retain stake
- Competitive strenghts of business:
o Relationships with brands, ability to source excess inventory etc. from A brands
o Bonded supplier status – can ship things in and out in Netherlands without paying taxes and duties
o Difficult to supply to the customers they do, e.g. within B&S
o Economies of scale in niches
o Seems well invested in terms of logistics/IT systems, incl. automated warehouse
Why is it trading where it does?
- Investors worried that covid impacts the business significantly